Sorrento CEO, BioReference CEO And The Great Outdoors

Mad Money w/ Jim Cramer

As Sorrento Therapeutics gains FDA approval for phase two of their COVID-19 treatment, how should investors approach the stock? CEO Dr. Henry Ji checks in to discuss the company's latest developments against coronavirus after today's 20% gain. Then, BioReference Labs CEO Dr. Jon Cohen joins Cramer to talk about testing the NBA, major league soccer, and expanding testing throughout the U.S. as the pandemic continues. Plus, Cramer's revealing 4 stocks in the outdoor space that could be worth looking at.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

2020-07-20 46 min

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.